Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E66.05 EPS (ttm)1.51 Insider Own0.48% Shs Outstand150.99M Perf Week-6.75%
Market Cap15.26B Forward P/E26.24 EPS next Y3.79 Insider Trans-7.25% Shs Float150.27M Perf Month-0.50%
Income228.52M PEG4.03 EPS next Q0.79 Inst Own100.21% Short Float4.29% Perf Quarter-10.86%
Sales3.20B P/S4.76 EPS this Y11.63% Inst Trans-1.18% Short Ratio3.09 Perf Half Y-24.26%
Book/sh23.79 P/B4.18 EPS next Y28.62% ROA2.50% Short Interest6.45M Perf Year-13.96%
Cash/sh2.82 P/C35.31 EPS next 5Y16.40% ROE6.57% 52W Range94.92 - 147.57 Perf YTD-16.99%
Dividend Est.0.40 (0.40%) P/FCF56.60 EPS past 5Y-6.65% ROI2.96% 52W High-32.60% Beta1.24
Dividend TTM0.40 (0.40%) Quick Ratio1.83 Sales past 5Y18.65% Gross Margin38.99% 52W Low4.78% ATR (14)4.25
Dividend Ex-DateOct 30, 2024 Current Ratio2.92 EPS Y/Y TTM13.46% Oper. Margin15.27% RSI (14)40.52 Volatility5.50% 3.82%
Employees8000 Debt/Eq1.17 Sales Y/Y TTM-12.41% Profit Margin7.13% Recom1.50 Target Price131.33
Option/ShortYes / Yes LT Debt/Eq1.15 EPS Q/Q132.56% Payout33.42% Rel Volume1.95 Prev Close97.91
Sales Surprise-2.97% EPS Surprise-1.16% Sales Q/Q-9.07% EarningsNov 04 BMO Avg Volume2.09M Price99.46
SMA20-6.62% SMA50-5.41% SMA200-17.54% Trades Volume4,080,726 Change1.58%
Date Action Analyst Rating Change Price Target Change
Sep-16-24Upgrade Citigroup Neutral → Buy $119 → $130
Aug-01-24Upgrade Seaport Research Partners Neutral → Buy $150
Aug-01-24Upgrade Mizuho Neutral → Outperform $143
Mar-01-24Initiated Wolfe Research Outperform $160
Feb-20-24Downgrade Mizuho Buy → Neutral $140
Feb-15-24Upgrade Craig Hallum Hold → Buy $150
Aug-04-23Downgrade Craig Hallum Buy → Hold
Jun-20-23Initiated BMO Capital Markets Outperform $129
Apr-03-23Downgrade Citigroup Buy → Neutral $92 → $86
Feb-15-23Reiterated Needham Buy $86 → $100
Dec-19-24 04:01AM
Dec-18-24 04:02AM
Dec-17-24 06:25AM
04:09AM
Dec-16-24 03:32AM
08:38PM Loading…
Dec-05-24 08:38PM
09:00AM
Nov-22-24 09:24AM
Nov-19-24 04:10PM
Nov-06-24 11:27AM
Nov-05-24 02:04AM
12:28AM
12:07AM
Nov-04-24 09:30AM
07:10AM
06:10AM Loading…
06:10AM
06:08AM
06:00AM
Nov-03-24 02:09AM
Oct-30-24 09:15AM
Oct-28-24 10:01AM
Oct-21-24 07:00PM
08:34AM
Oct-17-24 12:10PM
Oct-16-24 07:00AM
Oct-11-24 11:13PM
Sep-17-24 01:43PM
Sep-12-24 01:20AM
Sep-06-24 03:48AM
Sep-05-24 05:10PM
07:31AM Loading…
Aug-11-24 07:31AM
Aug-10-24 11:28AM
Aug-07-24 07:18AM
06:00AM
Jul-31-24 12:29PM
07:10AM
06:12AM
06:05AM
06:00AM
Jul-30-24 03:06AM
Jul-18-24 06:11PM
Jul-17-24 06:00PM
07:00AM
Jul-09-24 07:30AM
03:36AM
Jul-01-24 11:00PM
Jun-26-24 11:07AM
05:05AM
Jun-10-24 02:14PM
May-28-24 03:29PM
06:00AM
May-17-24 03:07PM
May-16-24 06:42AM
May-09-24 12:45PM
May-03-24 01:04AM
May-02-24 01:05PM
03:12AM
May-01-24 11:31PM
12:09PM
10:55AM
07:31AM
06:48AM
06:10AM
06:09AM
06:00AM
Apr-30-24 03:07AM
Apr-17-24 05:00PM
07:00AM
03:40AM
Apr-03-24 05:48AM
Mar-12-24 09:03PM
Mar-11-24 07:01PM
Mar-07-24 04:30PM
Mar-06-24 02:01AM
Mar-05-24 08:50AM
Mar-04-24 07:00AM
Feb-26-24 10:02AM
Feb-24-24 04:55AM
Feb-21-24 11:53PM
07:09AM
Feb-16-24 12:08AM
Feb-15-24 11:00AM
09:43AM
Feb-14-24 11:35PM
04:23PM
03:00PM
02:01AM
Feb-13-24 07:00PM
05:13PM
04:52PM
04:36PM
04:30PM
Feb-12-24 02:02AM
Feb-08-24 09:15AM
07:51AM
Jan-31-24 06:00PM
Jan-17-24 07:00AM
Jan-10-24 04:02AM
Jan-09-24 06:30PM
Nov-29-23 06:02AM
Entegris, Inc. engages in the development, manufacture, and supply of specialty materials for the microelectronics industry. It operates through the following segments: Materials Solutions (MS), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The MS segment provides materials-based solutions, such as chemical mechanical planarization slurries and pads, deposition materials, process chemistries and gases, formulated cleans, etchants, and other specialty materials. The MC segment offers advanced solutions that improve customers' yield, device reliability, and cost by filtering and purifying critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries. The AMH segment develops solutions that improve customers' yields by protecting critical materials during manufacturing, transportation, and storage, including products that monitor, protect, transport and deliver critical liquid chemistries, wafers, and other substrates for a broad set of applications in the semiconductor, life sciences, and other high-technology industries. The company was founded in 1966 and is headquartered in Billerica, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blachier OlivierSVP, Chief Strategy OfficerNov 18 '24Sale97.3250248,85511,515Nov 19 02:47 PM
Blachier OlivierOfficerNov 18 '24Proposed Sale97.3250248,855Nov 18 12:35 PM
Woodland Daniel D.President, APS DivisionJul 11 '24Option Exercise55.0515,000825,74149,980Jul 15 09:56 AM
Woodland Daniel D.President, APS DivisionJul 11 '24Sale145.0015,0002,175,00037,457Jul 15 09:56 AM
LOY BERTRANDPresident & CEOJul 03 '24Option Exercise31.1027,044841,068290,112Jul 08 03:28 PM
LOY BERTRANDPresident & CEOJul 03 '24Sale140.6327,0443,803,149263,068Jul 08 03:28 PM
Woodland Daniel D.President, APS DivisionJul 03 '24Option Exercise50.8515,000762,75052,318Jul 08 03:25 PM
Woodland Daniel D.President, APS DivisionJul 03 '24Sale140.0015,0002,100,00037,457Jul 08 03:25 PM
Haris Clinton M.SVP & President, MC DivisionMay 31 '24Sale124.745,005624,32434,600Jun 04 03:31 PM
O'Neill James AnthonySVP & CTOMay 23 '24Option Exercise67.963,619245,93315,499May 28 07:04 PM
O'Neill James AnthonySVP & CTOMay 23 '24Sale133.506,761902,59413,652May 28 07:04 PM
Blachier OlivierSVP, Chief Strategy OfficerMay 16 '24Sale133.841,986265,80612,356May 17 03:03 PM
LEDERER JAMES PDirectorMar 08 '24Sale146.211,500219,31517,902Mar 12 04:17 PM
GENTILCORE JAMESDirectorMar 07 '24Sale145.032,567372,29213,967Mar 11 04:19 PM
Sauer MichaelVP, Controller & CAOFeb 21 '24Sale132.541,897251,4281,779Feb 22 05:03 PM
Besnard MichaelSVP, Chief Commercial OfficerFeb 20 '24Option Exercise42.3112,667535,96015,523Feb 21 05:05 PM
Besnard MichaelSVP, Chief Commercial OfficerFeb 20 '24Sale135.7812,6671,719,92910,213Feb 21 05:05 PM
Rice Susan G.SVP, Global Human ResourcesFeb 16 '24Option Exercise32.2317,518564,56351,789Feb 21 05:01 PM
Rice Susan G.SVP, Global Human ResourcesFeb 16 '24Sale135.8617,5182,380,07242,931Feb 21 05:01 PM
Woodland Daniel D.President, APS DivisionFeb 16 '24Sale139.509,0001,255,50032,730Feb 21 04:57 PM
Richards NeilSVP, GOSCQFeb 20 '24Sale136.8133045,14720,744Feb 21 04:56 PM
Haris Clinton M.SVP & President, MC DivisionFeb 16 '24Option Exercise31.1012,868400,19551,562Feb 21 04:53 PM
Haris Clinton M.SVP & President, MC DivisionFeb 16 '24Sale137.5717,3662,388,99234,196Feb 21 04:53 PM
Colella JosephSVP and General CounselDec 22 '23Sale120.492,857344,24025,769Dec 27 12:08 PM
HBIO Harvard Bioscience Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.33 Insider Own8.35% Shs Outstand43.62M Perf Week-2.31%
Market Cap92.47M Forward P/E16.88 EPS next Y0.12 Insider Trans0.00% Shs Float39.97M Perf Month-2.31%
Income-14.24M PEG- EPS next Q0.05 Inst Own71.94% Short Float1.13% Perf Quarter-20.08%
Sales97.73M P/S0.95 EPS this Y-67.86% Inst Trans-1.43% Short Ratio2.90 Perf Half Y-25.96%
Book/sh1.50 P/B1.41 EPS next Y177.78% ROA-10.51% Short Interest0.45M Perf Year-57.80%
Cash/sh0.10 P/C20.23 EPS next 5Y10.00% ROE-20.40% 52W Range1.99 - 5.56 Perf YTD-60.56%
Dividend Est.- P/FCF110.08 EPS past 5Y6.80% ROI-13.40% 52W High-62.05% Beta1.27
Dividend TTM- Quick Ratio0.91 Sales past 5Y-1.02% Gross Margin52.89% 52W Low6.03% ATR (14)0.14
Dividend Ex-Date- Current Ratio2.06 EPS Y/Y TTM-326.10% Oper. Margin-4.65% RSI (14)43.18 Volatility5.93% 5.83%
Employees416 Debt/Eq0.70 Sales Y/Y TTM-13.15% Profit Margin-14.57% Recom1.00 Target Price6.25
Option/ShortYes / Yes LT Debt/Eq0.63 EPS Q/Q-279.66% Payout- Rel Volume2.08 Prev Close2.10
Sales Surprise-7.30% EPS Surprise-233.33% Sales Q/Q-13.38% EarningsNov 07 BMO Avg Volume155.18K Price2.11
SMA20-4.40% SMA50-8.39% SMA200-30.59% Trades Volume322,348 Change0.48%
Date Action Analyst Rating Change Price Target Change
Mar-10-23Upgrade The Benchmark Company Speculative Buy → Buy $3 → $4
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy
Dec-09-20Initiated Northland Capital Outperform $6
Nov-10-20Initiated KeyBanc Capital Markets Overweight $6
Jul-08-19Downgrade Janney Buy → Neutral $2
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Nov-08-24 02:08AM
Nov-07-24 07:12AM
07:00AM
Nov-06-24 07:50AM
Oct-29-24 05:00PM
05:43PM Loading…
Oct-09-24 05:43PM
Oct-03-24 08:00AM
Sep-18-24 07:30AM
Sep-17-24 08:00AM
Sep-05-24 04:05PM
Aug-08-24 08:37AM
08:30AM
Aug-02-24 08:00AM
Jun-06-24 04:05PM
May-23-24 04:05PM
04:05PM Loading…
May-16-24 04:05PM
May-08-24 10:14AM
03:03AM
May-07-24 11:56AM
08:41AM
08:15AM
07:13AM
07:00AM
Apr-29-24 08:45AM
Apr-09-24 09:00AM
Mar-12-24 10:30AM
Mar-11-24 08:00AM
Mar-08-24 10:48AM
Mar-07-24 10:51PM
01:56PM
12:53PM Loading…
12:53PM
07:32AM
07:00AM
Mar-06-24 08:30AM
Feb-27-24 05:10PM
Nov-20-23 04:40PM
Nov-09-23 04:30PM
02:28PM
Nov-07-23 09:58PM
08:00AM
07:28AM
07:00AM
Nov-06-23 04:30PM
Oct-30-23 09:00AM
Sep-18-23 08:57AM
Aug-15-23 10:20AM
Aug-08-23 09:43PM
09:15AM
08:05AM
07:18AM
Aug-03-23 06:30PM
Jul-27-23 06:36PM
Jun-22-23 07:55AM
Jun-21-23 08:50AM
Jun-20-23 08:01AM
Jun-13-23 12:21PM
May-25-23 08:50AM
May-24-23 08:26AM
May-23-23 10:17AM
May-09-23 09:40AM
08:50AM
07:15AM
May-02-23 05:01PM
08:35AM
Apr-27-23 06:14PM
Apr-26-23 12:02AM
Apr-25-23 08:41AM
08:01AM
Apr-18-23 05:10PM
Apr-17-23 04:45PM
Apr-11-23 08:28AM
Mar-28-23 06:14AM
Mar-20-23 02:00PM
Mar-16-23 05:14PM
09:25AM
Mar-13-23 02:49AM
Mar-09-23 10:59PM
07:00AM
Mar-06-23 05:09AM
Feb-28-23 04:10PM
Jan-04-23 10:43AM
Dec-12-22 08:30AM
Dec-05-22 05:09AM
Nov-08-22 06:05PM
04:01PM
Nov-07-22 12:30PM
Nov-02-22 05:15PM
Sep-26-22 10:23AM
Aug-24-22 06:11AM
Aug-03-22 10:48PM
Jul-28-22 10:39AM
Jul-26-22 04:50PM
Jun-15-22 08:40AM
May-29-22 08:46AM
May-16-22 09:35AM
May-04-22 08:25AM
07:00AM
May-03-22 05:25PM
Apr-26-22 09:00AM
Apr-21-22 04:05PM
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Green James WChief Executive OfficerJun 13 '24Buy2.9110,00029,1003,111,091Jun 14 04:02 PM
Green James WChief Executive OfficerJun 06 '24Buy3.0720,00061,4003,101,091Jun 07 04:02 PM